Marshall Wace, LLP Rockwell Medical, Inc. Call Options Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RMTI
# of Institutions
59Shares Held
9.3MCall Options Held
339KPut Options Held
43.3K-
Armistice Capital, LLC New York, NY3.58MShares$9.42 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.2MShares$3.17 Million0.0% of portfolio
-
Globeflex Capital L P San Diego, CA743KShares$1.95 Million0.29% of portfolio
-
Perkins Capital Management Inc350KShares$921,4881.37% of portfolio
-
Geode Capital Management, LLC Boston, MA307KShares$808,1830.0% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $28.1M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...